Evista to PREVENT breast cancer

May 2006

More women will be taking Evista to PREVENT breast cancer.

Preliminary results of the STAR study show that Evista (raloxifene) really does work as well as tamoxifen to reduce the risk of invasive breast cancer...and it's better tolerated.

Both drugs cut the number of expected breast cancer cases from 40 to 20 per 1000 postmenopausal women.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscription Options

Already a subscriber? Log in

Volume pricing available. Get a quote

Evista to PREVENT breast cancer
Cardiology Patients are asking if they should stop taking the combination of Plavix (clopidogrel) plus aspirin
Cardiology how to prevent or delay hypertension
Cardiology if chocolate is healthy
Women's Health whether VAGINAL estrogens are safe for women taking aromatase inhibitors
Women's Health Fem-V, a new at-home test to help determine how to treat vaginal infections
strategies for managing treatment-resistant depression
whether all ADHD drugs will get a black box warning about the risk of cardiac and psychiatric events
Infectious Diseases Truvada (tenofovir/emtricitabine) BEFORE risky behavior to prevent HIV infection
Ophthalmology Soft contact lens users are getting warnings about serious fungal eye infections and some ReNu solutions
Gastroenterology levofloxacin-based regimens for treatment-resistant H. pylori infections
Obesity & Weight Loss using the new diabetes drug, Byetta (exenatide), for weight loss
Medication Errors medication reconciliation
Pharmacists are having trouble stocking albuterol inhalers
Practice Niaspan and Niacor are no longer excluded under Medicare Part D

Evista to PREVENT breast cancer

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents